337 related articles for article (PubMed ID: 32006168)
1. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.
Lee SE; Lee JH; Han K; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY
Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168
[TBL] [Abstract][Full Text] [Related]
2. Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
Gweon HM; Cho N; Kim SY; Koo HR; Seo M; Chu A; Son EJ
Eur Radiol; 2017 Aug; 27(8):3211-3216. PubMed ID: 28083693
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
4. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
7. Synchronous BI-RADS category 3 lesions detected by preoperative breast MRI in patients with breast cancer: may follow-up be adequate?
Martin E; Boudier J; Salleron J; Henrot P
Eur Radiol; 2021 Dec; 31(12):9489-9498. PubMed ID: 33993330
[TBL] [Abstract][Full Text] [Related]
8. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
Aslan Ö; Oktay A; Eroğlu F
Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
[TBL] [Abstract][Full Text] [Related]
9. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
[No Abstract] [Full Text] [Related]
10. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
[TBL] [Abstract][Full Text] [Related]
11. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
Spick C; Bickel H; Polanec SH; Baltzer PA
Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
[TBL] [Abstract][Full Text] [Related]
12. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
Onishi N; Kataoka M; Kanao S; Kawai M; Iima M; Ohashi A; Toi M; Togashi K
Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
14. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
[TBL] [Abstract][Full Text] [Related]
15. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
17. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.
Lee AY; Ichikawa L; Lee JM; Lee CI; DeMartini WB; Joe BN; Wernli KJ; Sprague BL; Herschorn SD; Lehman CD
AJR Am J Roentgenol; 2016 Jan; 206(1):211-6. PubMed ID: 26700354
[TBL] [Abstract][Full Text] [Related]
18. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
19. Positive predictive value of BI-RADS MR imaging.
Mahoney MC; Gatsonis C; Hanna L; DeMartini WB; Lehman C
Radiology; 2012 Jul; 264(1):51-8. PubMed ID: 22589320
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]